Sources | Names Used |
---|---|
CTRPv2 | decitabine:navitoclax (2:1 mol/mol) |
PharmacoGx | decitabine:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TIGD3 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-09 |
mRNA | SLC18A2 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-09 |
mRNA | HNRNPUL1 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-09 |
mRNA | SEPT3 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-09 |
mRNA | DHPS | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-09 |
mRNA | ZMYM3 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-09 |
mRNA | ZBTB44 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-09 |
mRNA | RUNDC3A | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-09 |
mRNA | SNAP25 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-09 |
mRNA | ZNF260 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-09 |